SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy

作者: Hao Tang , Yue Xu , Zijian Zhang , Song Zeng , Wenbo Dong

DOI: 10.3892/MMR.2019.10045

关键词:

摘要: Epithelial-mesenchymal transition (EMT) has been demonstrated to serve a crucial role in the progression of interstitial fibrosis, which is one principal pathological features chronic allograft nephropathy (CAN). However, best our knowledge, mechanisms EMT CAN have not investigated. In present study, effect stromal cell-derived factor 1 (SDF-1) and Wnt signaling pathway on following kidney transplantation was The model established using Fisher 344 Lewis rats, treated with low-dose cyclosporine or without AMD3100. confirmed by alterations damage index scoring, western blotting reverse transcription-quantitative polymerase chain reaction. AMD3100 group, there were lower expression levels α-SMA higher E-cadherin, indicated that ameliorated tissue analyzed an mRNA + long noncoding (lnc)RNA microarray. A total 506 mRNAs 404 lncRNAs be significantly differentially expressed between two groups, revealed involvement SDF-1/CXC chemokine receptor 4 (CXCR4) pathway. SDF-1 induce vitro through upregulation α-SMA, downregulation E-cadherin wound healing assay, rat renal tubular epithelial cells via nuclear accumulation β-catenin, all inhibited either DKK-1. CXXC finger protein 5 (CXXC5), negative regulator pathway, downregulated treatment SDF-1, but Thus, CXXC5 may downstream SDF-1/CXCR4 EMT. conclusion, induces novel mechanism therapeutic target fibrosis rats.

参考文章(34)
K. E. Lamb, S. Lodhi, H.-U. Meier-Kriesche, Long-term renal allograft survival in the United States: a critical reappraisal. American Journal of Transplantation. ,vol. 11, pp. 450- 462 ,(2011) , 10.1111/J.1600-6143.2010.03283.X
R. B. Mannon, Therapeutic targets in the treatment of allograft fibrosis. American Journal of Transplantation. ,vol. 6, pp. 867- 875 ,(2006) , 10.1111/J.1600-6143.2006.01261.X
Jaanus Kahu, Lauri Kyllönen, Anne Räisänen-Sokolowski, Kaija Salmela, Donor risk score and baseline biopsy CADI value predict kidney graft outcome. Clinical Transplantation. ,vol. 25, ,(2011) , 10.1111/J.1399-0012.2011.01401.X
Hui Tao, Jing-Jing Yang, Kai-Hu Shi, Jun Li, Wnt signaling pathway in cardiac fibrosis: New insights and directions Metabolism-clinical and Experimental. ,vol. 65, pp. 30- 40 ,(2016) , 10.1016/J.METABOL.2015.10.013
Philippe Gatault, Dominique Bertrand, Matthias Büchler, Charlotte Colosio, Bruno Hurault de Ligny, Pierre-François Weestel, Jean-Philippe Rerolle, Antoine Thierry, Johnny Sayegh, Bruno Moulin, Renaud Snanoudj, Joseph Rivalan, Anne-Elisabeth Heng, Bénédicte Sautenet, Yvon Lebranchu, Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation. Transplant International. ,vol. 29, pp. 41- 50 ,(2016) , 10.1111/TRI.12656
HY Kim, JY Yoon, JH Yun, KW Cho, SH Lee, YM Rhee, HS Jung, HJ Lim, H Lee, J Choi, JN Heo, W Lee, KT No, D Min, KY Choi, None, CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation Cell Death & Differentiation. ,vol. 22, pp. 912- 920 ,(2015) , 10.1038/CDD.2014.238
C. von Toerne, C. Schmidt, J. Adams, E. Kiss, J. Bedke, S. Porubsky, N. Gretz, M. T. Lindenmeyer, C. D. Cohen, H.-J. Gröne, P. J. Nelson, Wnt Pathway Regulation in Chronic Renal Allograft Damage American Journal of Transplantation. ,vol. 9, pp. 2223- 2239 ,(2009) , 10.1111/J.1600-6143.2009.02762.X
Chien-Huang Wu, Jen-Shin Song, Kuei-Hua Chang, Jiing-Jyh Jan, Chiung-Tong Chen, Ming-Chen Chou, Kai-Chia Yeh, Ying-Chieh Wong, Chen-Tso Tseng, Szu-Huei Wu, Ching-Fang Yeh, Chung-Yu Huang, Min-Hsien Wang, Amit A. Sadani, Chun-Ping Chang, Chia-Yi Cheng, Lun K. Tsou, Kak-Shan Shia, Stem Cell Mobilizers Targeting Chemokine Receptor CXCR4: Renoprotective Application in Acute Kidney Injury Journal of Medicinal Chemistry. ,vol. 58, pp. 2315- 2325 ,(2015) , 10.1021/JM501769R
A. Zuk, M. Gershenovich, Y. Ivanova, R. T. MacFarland, S. P. Fricker, S. Ledbetter, CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury American Journal of Physiology-renal Physiology. ,vol. 307, ,(2014) , 10.1152/AJPRENAL.00685.2013